Cernostics raises Series B
Diagnostics company Cernostics has raised $1.4 million in Series B funding. Original investors participating in this round of funding include Novitas Capital, Geisinger Health System and the Pittsburgh Life Sciences Greenhouse.
4 December 2013•3 mins read
